Mint nicotine gum approved
This article was originally published in The Tan Sheet
FDA approves Dec. 29 Corona, Calif.-based Watson Laboratories' mint-flavored OTC Nicotine Polacrilex gum in 2 mg and 4 mg. The gum is the generic equivalent of GlaxoSmithKline Consumer Healthcare's Nicorette fresh mint gum, and will hit store shelves in early January. More than $300 million of nicotine gum was sold in the 12 months ending September 2008, according to Information Resources Inc. sales data
You may also be interested in...
FDA approves Morristown, N.J.-based Watson Laboratories' sale of 2 mg and 4 mg nicotine polacrilex gum coated with fruit and cinnamon flavors. The name brand equivalent Nicorette Fruit Chill and Cinnamon Sugar Coated Gums helped GlaxoSmithKline sell more than $305 million of the gum in the 12 months ending March 29, Watson says in a July 8 release. FDA approved Watson's mint-flavored equivalent of GlaxoSmithKline Consumer Healthcare's Nicorette gum in December 2008 (1"The Tan Sheet" Jan. 5, 2009, In Brief)
Not all technology platforms provide the expected benefit of filling in CMC review gaps and speeding coronavirus vaccine approvals.
A long-term, patient-centric group of investors is backing SparingVision's bid to develop a gene therapy treatment for retinitis pigmentosa that could be effective regardless of mutation.